Achieving robust fit-for-purpose analytical workflows that streamline cell and gene therapy development
Sponsor
Live30 webinars are thirty minute presentations designed to update you on the latest innovations, applications and data in a fast yet interactive format.
Expeditious development, manufacturing, and commercialization of cell and gene therapies require robust, fit-for-purpose analytical workflows. Often, a series of instruments are needed to meet the demand for efficient production of high-quality therapeutics, including viral vectors and cell populations. As a result, cell and gene therapy workflows become increasingly complex, impeding translation into the clinic. Simple Western, a capillary electrophoresis immunoassay, is a solution capable of enhancing and simplifying complex workflows across development.
In this webinar, we discuss how Simple Western provides quantitative protein measurements in a reproducible, fully automated, and high-throughput format. Specifically, we demonstrate that Simple Western can dramatically accelerate time to answer for several critical quality attributes (CQAs) including viral vector purity, identity, stability, and potency. In addition, we showcase the range of Simple Western applications across development, clinical trials, and manufacturing of cell and gene therapies.
Attendees will learn:
- How to measure multiple viral vector CQAs on the same instrument
- How to monitor signaling pathways during iPSC differentiation
- How Simple Western assays can be easily and reliably transferred between departments, company sites, and CROs
- How Simple Western is used across cell and gene therapy development, including in clinical trials and analytical development/quality control
SPEAKERS
You might also like
Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME
Precision in production: optimizing monitoring and quality control for high-value plasmids
Advancing cell therapy: innovations in polymer-based encapsulation and delivery
Pure and simple: understanding LNP analytics for better mRNA-based drugs
